Activin, Inhibin, and Follistatin in Ovarian Physiology

The Ovary: Second Edition

Volumn , Issue , 2004, Pages 273-287

  Chapman, Stacey C ^a   Kenny, Hilary A ^a   Woodruff, Teresa K ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 9644274571     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012444562-8/50017-3     Document Type: Chapter

References (208)

1. Piek E., Heldin C.H., Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 1999, 13:2105-2124.
2. Pangas S.A., Woodruff T.K. Activin signal transduction pathways. Trends. Endocrinol. Metab. 2000, 11:309-314.
3. Woodruff T.K., Mather J.P. Inhibin, activin and the female reproductive axis. Annu. Rev. Physiol. 1995, 57:219-244.
4. Luisi S., Florio P., Reis F.M., Petraglia F. Expression and secretion of activin A: Possible physiological and clinical implications. Eur. J. Endocrinol. 2001, 145:225-236.
5. Carroll R.S., Corrigan A.Z., Gharib S.D., Vale W., Chin W.W. Inhibin, activin, and follistatin: Regulation of follicle-stimulating hormone messenger ribonucleic acid levels. Mol. Endocrinol. 1989, 3:1969-1976.
6. Weiss J., Crowley W.F., Halvorson L.M., Jameson J.L. Perifusion of rat pituitary cells with gonadotropin-releasing hormone, activin, and inhibin reveals distinct effects on gonadotropin gene expression and secretion. Endocrinology 1993, 132:2307-2311.
7. Ethier J.F., Findlay J.K. Roles of activin and its signal transduction mechanisms in reproductive tissues. Reproduction 2001, 121:667-675.
8. Findlay J.K., Drummond A.E., Dyson M., Baillie A.J., Robertson D.M., Ethier J. Production and actions of inhibin and activin during folliculogenesis in the rat. Mol. Cell. Endocrinol. 2001, 180:139-144.
9. Findlay J.K., Drummond A.E., Dyson M.L., Baillie A.J., Robertson D.M., Ethier J.F. Recruitment and development of the follicle: The roles of the transforming growth factor-beta superfamily. Mol. Cell. Endocrinol. 2002, 191:35-43.
10. de Winter J.P., ten Dijke P., de Vries C.J., et al. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol. Cell. Endocrinol. 1996, 116:105-114.
11. Besecke L.M., Guendner M.J., Sluss P.A., et al. Pituitary follistatin regulates activin-mediated production of follicle-stimulating hormone during the rat estrous cycle. Endocrinology 1997, 138:2841-2848.
12. Hashimoto O., Nakamura T., Shoji H., Shimasaki S., Hayashi Y., Sugino H. A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate. J. Biol. Chem. 1997, 272:13835-13842.
13. Leal A.M., Takabe K., Wang L., et al. Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo. Endocrinology 2002, 143:964-969.
14. Corrigan A.Z., Bilezikjian L.M., Carroll R.S., et al. Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology 1991, 128:1682-1684.
15. Besecke L.M., Guendner M.J., Schneyer A.L., Bauer-Dantoin A.C., Jameson J.L., Weiss J. Gonadotropin-releasing hormone regulates follicle-stimulating hormone-beta gene expression through an activin/follistatin autocrine or paracrine loop. Endocrinology 1996, 137:3667-3673.
16. McConnell D.S., Wang Q., Sluss P.M., et al. A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J. Clin. Endocrinol. Metab. 1998, 83:851-858.
17. Burger H.G., McLachlan R.I., Bangah M., et al. Serum inhibin concentrations rise throughout normal male and female puberty. J. Clin. Endocrinol. Metab. 1988, 67:689-694.
18. McLachlan R.I., Robertson D.M., Healy D.L., Burger H.G., de Kretser D.M. Circulating immunoreactive inhibin levels during the normal human menstrual cycle. J. Clin. Endocrinol. Metab. 1987, 65:954-961.
19. Hasegawa Y., Miyamoto K., Igarashi M. Changes in serum concentrations of immunoreactive inhibin during the oestrous cycle of the rat. J. Endocrinol. 1989, 121:91-100.
20. Ackland J.F., D'Agostino J., Ringstrom S.J., Hostetler J.P., Mann B.G., Schwartz N.B. Circulating radioimmunoassayable inhibin during periods of transient follicle-stimulating hormone rise: Secondary surge and unilateral ovariectomy. Biol. Reprod. 1990, 43:347-352.
21. Reddi K., Wickings E.J., McNeilly A.S., Baird D.T., Hillier S.G. Circulating bioactive follicle-stimulating hormone and immunoreactive inhibin levels during the normal human menstrual cycle. Clin. Endocrinol. (Oxf.) 1990, 33:547-557.
22. Groome N.P., Illingworth P.J., O'Brien M., et al. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin. Endocrinol. (Oxf.) 1994, 40:717-723.
23. Groome N.P., Illingworth P.J., O'Brien M., et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 1996, 81:1401-1405.
24. Woodruff T.K., Besecke L.M., Groome N., Draper L.B., Schwartz N.B., Weiss J. Inhibin A and inhibin B are inversely correlated to follicle-stimulating hormone, yet are discordant during the follicular phase of the rat estrous cycle, and inhibin A is expressed in a sexually dimorphic manner. Endocrinology 1996, 137:5463-5467.
25. Meunier H., Rivier C., Evans R.M., Vale W. Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions. Proc. Natl. Acad. Sci. USA 1988, 85:247-251.
26. Woodruff T.K., D'Agostino J., Schwartz N.B., Mayo K.E. Decreased inhibin gene expression in preovulatory follicles requires primary gonadotropin surges. Endocrinology 1989, 124:2193-2199.
27. Schwall R.H., Mason A.J., Wilcox J.N., Bassett S.G., Zeleznik A.J. Localization of inhibin/activin subunit mRNAs within the primate ovary. Mol. Endocrinol. 1990, 4:75-79.
28. Meunier H., Cajander S.B., Roberts V.J., et al. Rapid changes in the expression of inhibin alpha-, beta A-, and beta B-subunits in ovarian cell types during the rat estrous cycle. Mol. Endocrinol. 1988, 2:1352-1363.
29. Woodruff T.K., D'Agostino J., Schwartz N.B., Mayo K.E. Dynamic changes in inhibin messenger RNAs in rat ovarian follicles during the reproductive cycle. Science 1988, 239:1296-1299.
30. Smith K.B., Millar M.R., McNeilly A.S., Illingworth P.J., Fraser H.M., Baird D.T. Immunocytochemical localization of inhibin alpha-subunit in the human corpus luteum. J. Endocrinol. 1991, 129:155-160.
31. Roberts V.J., Barth S., el-Roeiy A., Yen S.S. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J. Clin. Endocrinol. Metab. 1993, 77:1402-1410.
32. Davis J.S. Mechanisms of hormone action: Luteinizing hormone receptors and second-messenger pathways. Curr. Opin. Obstet. Gynecol. 1994, 6:254-261.
33. Feng Z.M., Li Y.P., Chen C.L. Analysis of the 5'-flanking regions of rat inhibin alpha- and beta-B-subunit genes suggests two different regulatory mechanisms. Mol. Endocrinol. 1989, 3:1914-1925.
34. Pei L., Dodson R., Schoderbek W.E., Maurer R.A., Mayo K.E. Regulation of the alpha inhibin gene by cyclic adenosine 3',5'-monophosphate after transfection into rat granulosa cells. Mol. Endocrinol. 1991, 5:521-534.
35. Mukherjee A., Urban J., Sassone-Corsi P., Mayo K.E. Gonadotropins regulate inducible cyclic adenosine 3',5'-monophosphate early repressor in the rat ovary: Implications for inhibin alpha subunit gene expression. Mol. Endocrinol. 1998, 12:785-800.
36. Tanimoto K., Yoshida E., Mita S., Nibu Y., Murakami K., Fukamizu A. Human activin betaA gene. Identification of novel 5' exon, functional promoter, and enhancers. J. Biol. Chem. 1996, 271:32760-32769.
37. Tuuri T., Eramaa M., Van Schaik R.H., Ritvos O. Differential regulation of inhibin/activin alpha- and beta A-subunit and follistatin mRNAs by cyclic AMP and phorbol ester in cultured human granulosa-luteal cells. Mol. Cell. Endocrinol. 1996, 121:1-10.
38. Ardekani A.M., Romanelli J.C., Mayo K.E. Structure of the rat inhibin and activin betaA-subunit gene and regulation in an ovarian granulosa cell line. Endocrinology 1998, 139:3271-3279.
39. Dykema J.C., Mayo K.E. Two messenger ribonucleic acids encoding the common beta B-chain of inhibin and activin have distinct 5'-initiation sites and are differentially regulated in rat granulosa cells. Endocrinology 1994, 135:702-711.
40. Eramaa M., Tuuri T., Hilden K., Ritvos O. Regulation of inhibin alpha- and beta A-subunit messenger ribonucleic acid levels by chorionic gonadotropin and recombinant follicle-stimulating hormone in cultured human granulosa-luteal cells. J. Clin. Endocrinol. Metab. 1994, 79:1670-1677.
41. Eramaa M., Ritvos O. Transforming growth factor-beta 1 and -beta 2 induce inhibin and activin beta B-subunit messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Fertil. Steril. 1996, 65:954-960.
42. Liu J., Hyden-Granskog C., Voutilainen R. Gonadotrophins inhibit and activin induces expression of inhibin/activin beta(B) subunit mRNA in cultured human granulosa-luteal cells. Mol. Hum. Reprod. 2001, 7:319-323.
43. Bondestam J., Kaivo-oja N., Kallio J., et al. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells. Mol. Cell. Endocrinol. 2002, 195:79.
44. Jaatinen R., Bondestam J., Raivio T., et al. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells. J. Clin. Endocrinol. Metab. 2002, 87:1254-1261.
45. Feng Z.M., Wu A.Z., Chen C.L. Testicular GATA-1 factor up-regulates the promoter activity of rat inhibin alpha-subunit gene in MA-10 Leydig tumor cells. Mol. Endocrinol. 1998, 12:378-390.
46. Feng Z.M., Wu A.Z., Zhang Z., Chen C.L. GATA-1 and GATA-4 transactivate inhibin/activin beta-B-subunit gene transcription in testicular cells. Mol. Endocrinol. 2000, 14:1820-1835.
47. Robertson D.M., Cahir N., Findlay J.K., Burger H.G., Groome N. The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma. J. Clin. Endocrinol. Metab. 1997, 82:889-896.
48. Plant T.M., Padmanabhan V., Ramaswamy S., et al. Circulating concentrations of dimeric inhibin A and B in the male rhesus monkey (Macaca mulatta). J. Clin. Endocrinol. Metab. 1997, 82:2617-2621.
49. Illingworth P.J., Groome N.P., Byrd W., et al. Inhibin-B: A likely candidate for the physiologically important form of inhibin in men. J. Clin. Endocrinol. Metab. 1996, 81:1321-1325.
50. Attisano L., Wrana J.L. Smads as transcriptional co-modulators. Curr. Opin. Cell. Biol. 2000, 12:235-243.
51. Afrakhte M., Moren A., Jossan S., et al. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem. Biophys. Res. Commun. 1998, 249:505-511.
52. Phillips D.J., de Kretser D.M. Follistatin: A multifunctional regulatory protein. Front. Neuroendocrinol. 1998, 19:287-322.
53. Mathews L.S., Vale W.W. Expression cloning of an activin receptor: A predicted transmembrane serine kinase. Cell 1991, 65:973-982.
54. Xu J., McKeehan K., Matsuzaki K., McKeehan W.L. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J. Biol. Chem. 1995, 270:6308-6313.
55. Martens J.W., de Winter J.P., Timmerman M.A., et al. Inhibin interferes with activin signaling at the level of the activin receptor complex in Chinese hamster ovary cells. Endocrinology 1997, 138:2928-2936.
56. Bilezikjian L.M., Blount A.L., Campen C.A., Gonzalez-Manchon C., Vale W. Activin-A inhibits proopiomelanocortin messenger RNA accumulation and adrenocorticotropin secretion of AtT20 cells. Mol. Endocrinol. 1991, 5:1389-1395.
57. Schwall R.H., Robbins K., Jardieu P., Chang L., Lai C., Terrell T.G. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 1993, 18:347-356.
58. Lebrun J.J., Vale W.W. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Mol. Cell. Biol. 1997, 17:1682-1691.
59. Draper L.B., Matzuk M.M., Roberts V.J., et al. Identification of an inhibin receptor in gonadal tumors from inhibin alpha-subunit knockout mice. J. Biol. Chem. 1998, 273:398-403.
60. Hertan R., Farnworth P.G., Fitzsimmons K.L., Robertson D.M. Identification of high affinity binding sites for inhibin on ovine pituitary cells in culture. Endocrinology 1999, 140:6-12.
61. Chong H., Pangas S.A., Bernard D.J., et al. Structure and expression of a membrane component of the inhibin receptor system. Endocrinology 2000, 141:2600-2607.
62. Farnworth P.G., Harrison C.A., Leembruggen P., et al. Inhibin binding sites and proteins in pituitary, gonadal, adrenal, and bone cells. Mol. Cell. Endocrinol. 2001, 180:63-71.
63. Harrison C.A., Farnworth P.G., Chan K.L., et al. Identification of specific inhibin A-binding proteins on mouse Leydig (TM3) and sertoli (TM4) cell lines. Endocrinology 2001, 142:1393-1402.
64. Lewis K.A., Gray P.C., Blount A.L., et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 2000, 404:411-414.
65. Esparza-Lopez J., Montiel J.L., Vilchis-Landeros M.M., Okadome T., Miyazono K., Lopez-Casillas F. Ligand binding and functional properties of betaglycan, a coreceptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A. J. Biol. Chem. 2001, 276:14588-14596.
66. Chapman S.C., Bernard D.J., Jelen J., Woodruff T.K. Properties of inhibin binding to betaglycan, InhBP/p120, and the activin type II receptors. Mol. Cell. Endocrinol. 2002, 196:79.
67. Alak B.M., Smith G.D., Woodruff T.K., Stouffer R.L., Wolf D.P. Enhancement of primate oocyte maturation and fertilization in vitro by inhibin A and activin A. Fertil. Steril. 1996, 66:646-653.
68. Lejeune H., Chuzel F., Sanchez P., Durand P., Mather J.P., Saez J.M. Stimulating effect of both human recombinant inhibin A and activin A on immature porcine Leydig cell functions in vitro. Endocrinology 1997, 138:4783-4791.
69. Kretzschmar M., Doody J., Timokhina I., Massague J. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev. 1999, 13:804-816.
70. McCullaugh E. Dual endocrine activity of the testes. Science 1932, 76:19-20.
71. Schwartz N.B., Channing C.P. Evidence for ovarian "inhibin": suppression of the secondary rise in serum follicle stimulating hormone levels in proestrous rats by injection of porcine follicular fluid. Proc. Natl. Acad. Sci. USA 1977, 74:5721-5724.
72. Lumpkin M.D., DePaolo L.V., Negro-Vilar A. Pulsatile release of follicle-stimulating hormone in ovariectomized rats is inhibited by porcine follicular fluid (inhibin). Endocrinology 1984, 114:201-206.
73. Rivier C., Rivier J., Vale W. Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rat. Science 1986, 234:205-208.
74. DePaolo L.V. Hypersecretion of follicle-stimulating hormone (FSH) after ovariectomy of hypophysectomized, pituitary-grafted rats: Implications for local regulatory control of FSH. Endocrinology 1991, 128:1731-1740.
75. Robertson D.M., Prisk M., McMaster J.W., Irby D.C., Findlay J.K., de Kretser D.M. Serum FSH-suppressing activity of human recombinant inhibin A in male and female rats. J. Reprod. Fertil. 1991, 91:321-328.
76. Carroll R.S., Kowash P.M., Lofgren J.A., Schwall R.H., Chin W.W. In vivo regulation of FSH synthesis by inhibin and activin. Endocrinology 1991, 129:3299-3304.
77. Rivier C., Schwall R., Mason A., Burton L., Vale W. Effect of recombinant inhibin on gonadotropin secretion during proestrus and estrus in the rat. Endocrinology 1991, 128:2223-2228.
78. Rivier C., Schwall R., Mason A., Burton L., Vaughan J., Vale W. Effect of recombinant inhibin on luteinizing hormone and follicle-stimulating hormone secretion in the rat. Endocrinology 1991, 128:1548-1554.
79. Woodruff T.K., Krummen L.A., Lyon R.J., Stocks D.L., Mather J.P. Recombinant human inhibin A and recombinant human activin A regulate pituitary and ovarian function in the adult female rat. Endocrinology 1993, 132:2332-2341.
80. Rivier C., Vale W. Immunoneutralization of endogenous inhibin modifies hormone secretion and ovulation rate in the rat. Endocrinology 1989, 125:152-157.
81. Ling N., Ying S.Y., Ueno N., et al. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 1986, 321:779-782.
82. Vale W., Rivier J., Vaughan J., et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986, 321:776-779.
83. Carroll R.S., Corrigan A.Z., Vale W., Chin W.W. Activin stabilizes follicle-stimulating hormone-beta messenger ribonucleic acid levels. Endocrinology 1991, 129:1721-1726.
84. Rivier C., Vale W. Effect of recombinant activin-A on gonadotropin secretion in the female rat. Endocrinology 1991, 129:2463-2465.
85. DePaolo L.V., Bicsak T.A., Erickson G.F., Shimasaki S., Ling N. Follistatin and activin: A potential intrinsic regulatory system within diverse tissues. Proc. Soc. Exp. Biol. Med. 1991, 198:500-512.
86. Roberts V., Meunier H., Vaughan J., et al. Production and regulation of inhibin subunits in pituitary gonadotropes. Endocrinology 1989, 124:552-554.
87. DePaolo L.V., Bald L.N., Fendly B.M. Passive immunoneutralization with a monoclonal antibody reveals a role for endogenous activin-B in mediating FSH hypersecretion during estrus and following ovariectomy of hypophysectomized, pituitary-grafted rats. Endocrinology 1992, 130:1741-1743.
88. Bilezikjian L.M., Vaughan J.M., Vale W.W. Characterization and the regulation of inhibin/activin subunit proteins of cultured rat anterior pituitary cells. Endocrinology 1993, 133:2545-2553.
89. Halvorson L.M., Weiss J., Bauer-Dantoin A.C., Jameson J.L. Dynamic regulation of pituitary follistatin messenger ribonucleic acids during the rat estrous cycle. Endocrinology 1994, 134:1247-1253.
90. Bilezikjian L.M., Corrigan A.Z., Blount A.L., Chen Y., Vale W.W. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells. Endocrinology 2001, 142:1065-1072.
91. Sehested A., Juul A.A., Andersson A.M., et al. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: Relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J. Clin. Endocrinol. Metab. 2000, 85:1634-1640.
92. Bergada I., Bergada C., Campo S. Role of inhibins in childhood and puberty. J. Pediatr. Endocrinol. Metab. 2001, 14:343-353.
93. Raivio T., Dunkel L. Inhibins in childhood and puberty. Best Pract. Res. Clin. Endocrinol. Metab. 2002, 16:43-52.
94. Foster C.M., Phillips D.J., Wyman T., Evans L.W., Groome N.P., Padmanabhan V. Changes in serum inhibin, activin, and follistatin concentrations during puberty in girls. Hum. Reprod. 2000, 15:1052-1057.
95. Yokota H., Yamada K., Liu X., et al. Paradoxical action of activin A on folliculogenesis in immature and adult mice. Endocrinology 1997, 138:4572-4576.
96. Liu X., Andoh K., Abe Y., et al. A comparative study on transforming growth factor-beta and activin A for preantral follicles from adult, immature, and diethylstilbestrol-primed immature mice. Endocrinology 1999, 140:2480-2485.
97. Miro F., Hillier S.G. Modulation of granulosa cell deoxyribonucleic acid synthesis and differentiation by activin. Endocrinology 1996, 137:464-468.
98. Zhao J., Taverne M.A., van der Weijden G.C., Bevers M.M., van den Hurk R. Effect of activin A on in vitro development of rat preantral follicles and localization of activin A and activin receptor II. Biol. Reprod. 2001, 65:967-977.
99. Woodruff T.K., Lyon R.J., Hansen S.E., Rice G.C., Mather J.P. Inhibin and activin locally regulate rat ovarian folliculogenesis. Endocrinology 1990, 127:3196-3205.
100. Uilenbroek J.T., Richards J.S. Ovarian follicular development during the rat estrous cycle: Gonadotropin receptors and follicular responsiveness. Biol. Reprod. 1979, 20:1159-1165.
101. Camp T.A., Rahal J.O., Mayo K.E. Cellular localization and hormonal regulation of follicle-stimulating hormone and luteinizing hormone receptor messenger RNAs in the rat ovary. Mol. Endocrinol. 1991, 5:1405-1417.
102. Erickson G. Folliculogenesis, ovulation, and luteogenesis. Endocrinology 2001, 2061-2071. W. B. Saunders Co., Philadelphia. 4th ed. L. DeGroot, J.L. Jameson (Eds.).
103. Miro F, Hillier SG Relative effects of activin and inhibin on steroid hormone synthesis in primate granulosa cells. J. Clin. Endocrinol. Metab. 1992, 75:1556-1561.
104. Miro F., Smyth C.D., Hillier S.G. Development-related effects of recombinant activin on steroid synthesis in rat granulosa cells. Endocrinology 1991, 129:3388-3394.
105. Stouffer R.L., Woodruff T.K., Dahl K.D., Hess D.L., Mather J.P., Molskness T.A. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis during the menstrual cycle in rhesus monkeys. J. Clin. Endocrinol. Metab. 1993, 77:241-248.
106. Hillier S.G., Yong E.L., Illingworth P.J., Baird D.T., Schwall R.H., Mason A.J. Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol. Cell. Endocrinol. 1991, 75:R1-R6.
107. Hillier S.G., Yong E.L., Illingworth P.J., Baird D.T., Schwall R.H., Mason A.J. Effect of recombinant activin on androgen synthesis in cultured human thecal cells. J. Clin. Endocrinol. Metab. 1991, 72:1206-1211.
108. Hsueh A.J., Dahl K.D., Vaughan J., et al. Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis. Proc. Natl. Acad. Sci. USA 1987, 84:5082-5086.
109. Miro F., Smyth C.D., Whitelaw P.F., Milne M., Hillier S.G. Regulation of 3 beta-hydroxysteroid dehydrogenase delta 5/delta 4-isomerase and cholesterol side-chain cleavage cytochrome P450 by activin in rat granulosa cells. Endocrinology 1995, 136:3247-3252.
110. Sawetawan C., Carr B.R., McGee E., Bird I.M., Hong T.L., Rainey W.E. Inhibin and activin differentially regulate androgen production and 17 alpha-hydroxylase expression in human ovarian thecal-like tumor cells. J. Endocrinol. 1996, 148:213-221.
111. Nakamura M., Minegishi T., Hasegawa Y., et al. Effect of an activin A on follicle-stimulating hormone (FSH) receptor messenger ribonucleic acid levels and FSH receptor expressions in cultured rat granulosa cells. Endocrinology 1993, 133:538-544.
112. Hasegawa Y., Miyamoto K., Abe Y., et al. Induction of follicle stimulating hormone receptor by erythroid differentiation factor on rat granulosa cell. Biochem. Biophys. Res. Commun. 1988, 156:668-674.
113. Xiao S., Robertson D.M., Findlay J.K. Effects of activin and follicle-stimulating hormone (FSH)-suppressing protein/follistation on FSH receptors and differentiation of cultured rat granulosa cells. Endocrinology 1992, 131:1009-1016.
114. Nakamura M., Nakamura K., Igarashi S., et al. Interaction between activinA and cAMP in the induction of FSH receptor in cultured rat granulosa cells. J. Endocrinol. 1995, 147:103-110.
115. Tano M., Minegishi T., Nakamura K., Karino S., Ibuki Y., Miyamoto K. Transcriptional and post-transcriptional regulation of FSH receptor in rat granulosa cells by cyclic AMP and activin. J. Endocrinol. 1997, 153:465-473.
116. Lockwood G.M., Ledger W.L., Barlow D.H., Groome N.P., Muttukrishna S. Identification of the source of inhibins at the time of conception provides a diagnostic role for them in very early pregnancy. Am. J. Reprod. Immunol. 1998, 40:303-308.
117. Ohshima K., Arai K.Y., Kishi H., et al. Potential role of activin A in follicular development during the second half of pregnancy in the golden hamster: Utero-placental source of activin A. J. Endocrinol. 2002, 172:247-253.
118. Brannian J.D., Woodruff T.K., Mather J.P., Stouffer R.L. Activin-A inhibits progesterone production by macaque luteal cells in culture. J. Clin. Endocrinol. Metab. 1992, 75:756-761.
119. Lockwood G.M., Muttukrishna S., Ledger W.L. Inhibins and activins in human ovulation, conception and pregnancy. Hum. Reprod. Update 1998, 4:284-295.
120. Woodruff T.K., Sluss P., Wang E., Janssen I., Mersol-Barg M.S. Activin A and follistatin are dynamically regulated during human pregnancy. J. Endocrinol. 1997, 152:167-174.
121. Baker T. A quantitative and cytological study of germ cells in human ovaries. Proc. R. Soc. Biol. 1963, 158:417.
122. Block E. Quantitative morphological investigations of the follicular system in women. Acta. Endocrinol. 1951, 8:33.
123. Richardson S.J., Senikas V., Nelson J.F. Follicular depletion during the menopausal transition: Evidence for accelerated loss and ultimate exhaustion. J. Clin. Endocrinol. Metab. 1987, 65:1231-1237.
124. Seifer D.B., Lambert-Messerlian G., Hogan J.W., Gardiner A.C., Blazar A.S., Berk C.A. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil. Steril. 1997, 67:110-114.
125. Seifer D.B., Scott R.T., Bergh P.A., et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil. Steril. 1999, 72:63-65.
126. Richardson S.J., Nelson J.F. Follicular depletion during the menopausal transition. Ann. N.Y. Acad. Sci. 1990, 592:13-20. discussion 44-51.
127. Tepper R., Zalel Y., Markov S., Cohen I., Beyth Y. Ovarian volume in postmenopausal women-suggestions to an ovarian size nomogram for menopausal age. Acta. Obstet. Gynecol. Scand. 1995, 74:208-211.
128. Faddy M.J., Gosden R.G. A model conforming the decline in follicle numbers to the age of menopause in women. Hum. Reprod. 1996, 11:1484-1486.
129. Costoff A., Mahesh V.B. Primordial follicles with normal oocytes in the ovaries of postmenopausal women. J. Am. Geriatr. Soc. 1975, 23:193-196.
130. Klein N.A., Battaglia D.E., Miller P.B., Branigan E.F., Giudice L.C., Soules M.R. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age. J. Clin. Endocrinol. Metab. 1996, 81:1946-1951.
131. Hee J., MacNaughton J., Bangah M., Burger H.G. Perimenopausal patterns of gonadotrophins, immunoreactive inhibin, oestradiol, and progesterone. Maturitas 1993, 18:9-20.
132. Ala-Fossi S.L., Maenpaa J., Blauer M., Aine R., Tuohimaa P., Punnonen R. Inhibin A and B in peri- and postmenopause. Maturitas 1998, 30:273-281.
133. Burger H.G., Cahir N., Robertson D.M., et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin. Endocrinol. (Oxf.) 1998, 48:809-813.
134. Soules M.R., Battaglia D.E., Klein N.A. Inhibin and reproductive aging in women. Maturitas 1998, 30:193-204.
135. Klein N.A., Illingworth P.J., Groome N.P., McNeilly A.S., Battaglia D.E., Soules MR Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: A study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J. Clin. Endocrinol. Metab. 1996, 81:2742-2745.
136. Santoro N., Adel T., Skurnick J.H. Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil. Steril. 1999, 71:658-662.
137. Welt C.K., McNicholl D.J., Taylor A.E., Hall J.E. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J. Clin. Endocrinol. Metab. 1999, 84:105-111.
138. Robertson D.M., Burger H.G. Reproductive hormones: Ageing and the perimenopause. Acta. Obstet. Gynecol. Scand. 2002, 81:612-616.
139. Klein N.A., Battaglia D.E., Woodruff T.K., et al. Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age. J. Clin. Endocrinol. Metab. 2000, 85:4520-4525.
140. MacNaughton J., Banah M., McCloud P., Hee J., Burger H. Age-related changes in follicle-stimulating hormone, luteinizing hormone, oestradiol, and immunoreactive inhibin in women of reproductive age. Clin. Endocrinol. (Oxf.) 1992, 36:339-345.
141. Burger H.G., Dudley E.C., Hopper J.L., et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J. Clin. Endocrinol. Metab. 1999, 84:4025-4030.
142. Longcope C. Endocrine function of the post-menopausal ovary. J. Soc. Gynecol. Investig. 2001, 8:S67-S68.
143. Matzuk M.M., Kumar T.R., Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 1995, 374:356-360.
144. Matzuk M.M., Kumar T.R., Shou W., et al. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Rec. Prog. Hormone Res. 1996, 51:123-154. discussion 155-157.
145. Chang H., Lau A.L., Matzuk M.M. Studying TGF-beta superfamily signaling by knockouts and knockins. Mol. Cell. Endocrinol. 2001, 180:39-46.
146. Cho B.N., McMullen M.L., Pei L., Yates C.J., Mayo K.E. Reproductive deficiencies in transgenic mice expressing the rat inhibin alpha-subunit gene. Endocrinology 2001, 142:4994-5004.
147. McMullen M.L., Cho B.N., Yates C.J., Mayo K.E. Gonadal pathologies in transgenic mice expressing the rat inhibin alpha-subunit. Endocrinology 2001, 142:5005-5014.
148. Pierson T.M., Wang Y., DeMayo F.J., Matzuk M.M., Tsai S.Y., Omalley B.W. Regulable expression of inhibin A in wild-type and inhibin alpha null mice. Mol. Endocrinol. 2000, 14:1075-1085.
149. Vassalli A., Matzuk M.M., Gardner H.A., Lee K.F., Jaenisch R. Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev. 1994, 8:414-427.
150. Brown C.W., Houston-Hawkins D.E., Woodruff T.K., Matzuk M.M. Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions. Nat. Genet. 2000, 25:453-457.
151. Westhoff C. Ovarian cancer. Annu. Rev. Public Health 1996, 17:85-96.
152. Holschneider C.H., Berek J.S. Ovarian cancer: Epidemiology, biology, and prognostic factors. Semin. Surg. Oncol. 2000, 19:3-10.
153. Risbridger G.P., Schmitt J.F., Robertson D.M. Activins and inhibins in endocrine and other tumors. Endocr. Rev. 2001, 22:836-858.
154. Zheng W., Luo M.P., Welt C., et al. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Gynecol. Oncol. 1998, 69:23-31.
155. Flemming P., Wellmann A., Maschek H., Lang H., Georgii A. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. A report of three cases with late metastasis, being previously misinterpreted as hemangiopericytoma. Am. J. Surg. Pathol. 1995, 19:927-933.
156. Gurusinghe C.J., Healy D.L., Jobling T., Mamers P., Burger H.G. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol. Oncol. 1995, 57:27-32.
157. Flemming P., Grothe W., Maschek H., Petry K.U., Wellmann A., Georgii A. The site of inhibin production in ovarian neoplasms. Histopathology 1996, 29:465-468.
158. Arora D.S., Cooke I.E., Ganesan T.S., et al. Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary. J. Pathol. 1997, 181:413-418.
159. Fuller P.J., Chu S., Jobling T., Mamers P., Healy D.L., Burger H.G. Inhibin subunit gene expression in ovarian cancer. Gynecol. Oncol. 1999, 73:273-279.
160. Ala-Fossi S.L., Aine R., Punnonen R., Maenpaa J. Is potential to produce inhibins related to prognosis in ovarian granulosa cell tumors?. Eur. J. Gynaecol. Oncol. 2000, 21:187-189.
161. Ala-Fossi S.L., Maenpaa J., Blauer M., Tuohimaa P., Punnonen R. Inhibin A, B, and pro-alphaC in serum and peritoneal fluid in postmenopausal patients with ovarian tumors. J. Endocrinol. Eur. J. Endocrinol. 2000, 142:334-339.
162. Gebhart J.B., Roche P.C., Keeney G.L., Lesnick T.G., Podratz K.C. Assessment of inhibin and p53 in granulosa cell tumors of the ovary. Gynecol. Oncol. 2000, 77:232-236.
163. Fuller P.J., Zumpe E.T., Chu S., Mamers P., Burger H.G. Inhibin-activin receptor subunit gene expression in ovarian tumors. J. Clin. Endocrinol. Metab. 2002, 87:1395-1401.
164. Reis F.M., Faletti A., Luisi S., et al. High concentrations of inhibin A and inhibin B in ovarian serous cystadenoma: Relationship with oestradiol and nitric oxide metabolites. Mol. Hum. Reprod. 2000, 6:1079-1083.
165. Healy D.L., Burger H.G., Mamers P., et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N. Engl. J. Med. 1993, 329:1539-1542.
166. Burger H.G., Baillie A., Drummond A.E., et al. Inhibin and ovarian cancer. J. Reprod. Immunol. 1998, 39:77-87.
167. Burger H.G., Robertson D.M., Cahir N., et al. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours. Clin. Endocrinol. (Oxf.) 1996, 44:413-418.
168. Robertson D.M., Cahir N., Burger H.G., Mamers P., Groome N. Inhibin forms in serum from post-menopausal women with ovarian cancers. Clin. Endocrinol. (Oxf.) 1999, 50:381-386.
169. Lappohn R.E., Burger H.G., Bouma J., Bangah M., Krans M., de Bruijn H.W. Inhibin as a marker for granulosa-cell tumors. N. Engl. J. Med. 1989, 321:790-793.
170. Healy D.L., Mamers P., Bangah M., Burger H.G. Clinical and pathophysiological aspects of inhibin. Hum. Reprod. 1993, 8(Suppl 2):138-140.
171. Cooke I., O'Brien M., Charnock F.M., Groome N., Ganesan T.S. Inhibin as a marker for ovarian cancer. Br. J. Cancer 1995, 71:1046-1050.
172. Burger H.G., Fuller P.J., Chu S., et al. The inhibins and ovarian cancer. Mol. Cell. Endocrinol. 2001, 180:145-148.
173. Petraglia F., Luisi S., Pautier P., et al. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. J. Clin. Endocrinol. Metab. 1998, 83:1029-1032.
174. Lambert-Messerlian G.M., Steinhoff M., Zheng W., et al. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. Gynecol. Oncol. 1997, 65:512-516.
175. Robertson D.M., Stephenson T., Pruysers E., et al. Inhibins/activins as diagnostic markers for ovarian cancer. Mol. Cell. Endocrinol. 2002, 191:97-103.
176. Frias A.E., Li H., Keeney G.L., Podratz K.C., Woodruff T.K. Preoperative serum level of inhibin A is an independent prognostic factor for the survival of postmenopausal women with epithelial ovarian carcinoma. Cancer 1999, 85:465-471.
177. McCluggage W.G. Recent advances in immunohistochemistry in gynaecological pathology. Histopathology 2002, 40:309-326.
178. Robertson D.M., Stephenson T., Pruysers E., et al. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from post-menopausal women with ovarian cancer. J. Clin. Endocrinol. Metab. 2002, 87:816-824.
179. Minegishi T., Kameda T., Hirakawa T., Abe K., Tano M., Ibuki Y. Expression of gonadotropin and activin receptor messenger ribonucleic acid in human ovarian epithelial neoplasms. Clin. Cancer Res. 2000, 6:2764-2770.
180. Ito I., Minegishi T., Fukuda J., Shinozaki H., Auersperg N., Leung P.C. Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma. Br. J. Cancer 2000, 82:1415-1420.
181. Choi K.C., Kang S.K., Nathwani P.S., Cheng K.W., Auersperg N., Leung P.C. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE). Mol. Cell. Endocrinol. 2001, 174:99-110.
182. Di Simone N., Crowley W.F., Wang Q.F., Sluss P.M., Schneyer A.L. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: A potential role in autocrine growth regulation. Endocrinology 1996, 137:486-494.
183. Welt C.K., Lambert-Messerlian G., Zheng W., Crowley W.F., Schneyer A.L. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. J. Clin. Endocrinol. Metab. 1997, 82:3720-3727.
184. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J. Clin. Endocrinol. Metab. 1998, 83:3078-3082.
185. Dewailly D. Definition of polycystic ovary syndrome. Hum. Fertil. (Camb.) 2000, 3:73-76.
186. Dunaif A., Thomas A. Current concepts in the polycystic ovary syndrome. Annu. Rev. Med. 2001, 52:401-419.
187. Urbanek M., Legro R.S., Driscoll D.A., et al. Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin. Proc. Natl. Acad. Sci. USA 1999, 96:8573-8578.
188. Liao W.X., Roy A.C., Ng S.C. Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome. Mol. Hum. Reprod. 2000, 6:587-590.
189. Urbanek M., Wu X., Vickery K.R., et al. Allelic variants of the follistatin gene in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2000, 85:4455-4461.
190. Pigny P., Cortet-Rudelli C., Decanter C., et al. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: Effects of being overweight and relevance to hyperandrogenism. Fertil. Steril. 2000, 73:972-977.
191. Mizunuma H., Andoh K., Obara M., et al. Serum immunoreactive inhibin levels in polycystic ovarian disease (PCOD) and hypogonadotropic amenorrhea. Endocr. J. 1994, 41:409-414.
192. Pigny P., Desailloud R., Cortet-Rudelli C., et al. Serum alpha-inhibin levels in polycystic ovary syndrome: Relationship to the serum androstenedione level. J. Clin. Endocrinol. Metab. 1997, 82:1939-1943.
193. Anderson R.A., Groome N.P., Baird D.T. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce monoovulation. Clin. Endocrinol. (Oxf.) 1998, 48:577-584.
194. Lockwood G.M., Muttukrishna S., Groome N.P., Matthews D.R., Ledger W.L. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: A possible mechanism regulating emergence of the dominant follicle. J. Clin. Endocrinol. Metab. 1998, 83:1730-1735.
195. Norman R.J., Milner C.R., Groome N.P., Robertson D.M. Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome. Hum. Reprod. 2001, 16:668-672.
196. Lockwood G.M. The role of inhibin in polycystic ovary syndrome. Hum. Fertil. (Camb.) 2000, 3:86-92.
197. Lambert-Messerlian G.M., Hall J.E., Sluss P.M., et al. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J. Clin. Endocrinol. Metab. 1994, 79:45-50.
198. Erickson G.F., Chung D.G., Sit A., DePaolo L.V., Shimasaki S., Ling N. Follistatin concentrations in follicular fluid of normal and polycystic ovaries. Hum. Reprod. 1995, 10:2120-2124.
199. Magoffin D.A., Jakimiuk A.J. Inhibin A, inhibin B, and activin A concentrations in follicular fluid from women with polycystic ovary syndrome. Hum. Reprod. 1998, 13:2693-2698.
200. Laven J.S., Imani B., Eijkemans M.J., de Jong F.H., Fauser B.C. Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility. Hum. Reprod. 2001, 16:1359-1364.
201. Fujiwara T., Sidis Y., Welt C., et al. Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles. J. Clin. Endocrinol. Metab. 2001, 86:4206-4215.
202. Coulam C.B., Adamson S.C., Annegers J.F. Incidence of premature ovarian failure. Obstet. Gynecol. 1986, 67:604-606.
203. Vegetti W., Grazia, Tibiletti M., Testa G., et al. Inheritance in idiopathic premature ovarian failure: Analysis of 71 cases. Hum. Reprod. 1998, 13:1796-1800.
204. van Kasteren Y.M., Hundscheid R.D., Smits A.P., Cremers F.P., van Zonneveld P., Braat D.D. Familial idiopathic premature ovarian failure: An overrated and underestimated genetic disease?. Hum. Reprod. 1999, 14:2455-2459.
205. Christin-Maitre S., Vasseur C., Portnoi M.F., Bouchard P. Genes and premature ovarian failure. Mol. Cell. Endocrinol. 1998, 145:75-80.
206. Lutjen P.J., Findlay J.K., Trounson A.O., Leeton J.F., Chan L.K. Effect on plasma gonadotropins of cyclic steroid replacement in women with premature ovarian failure. J. Clin. Endocrinol. Metab. 1986, 62:419-423.
207. Shelling A.N., Burton K.A., Chand A.L., et al. Inhibin: A candidate gene for premature ovarian failure. Hum. Reprod. 2000, 15:2644-2649.
208. Marozzi A., Porta C., Vegetti W., et al. Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. Hum. Reprod. 2002, 17:1741-1745.